Andrea Chiesi

Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom.

Part of Valline Srl, Chiesi SA (Belgium) is a Belgian pharmaceutical company specializing in the treatment of respiratory diseases, neonatology, rare diseases, and special care. Chiesi SA (Belgium is based in Machelen, BE. The company's focus on innovation and patient care has led to collaborations with other organizations, such as Affibody, and the development of new treatments for rare diseases. Chiesi SA (Belgium is committed to sustainability and participates in events such as Climbing for Life. The company was founded in 2010 by Giacomo Chiesi, and the CEO is Alberto Chiesi.

Chiesi SAS wholesales and distributes pharmaceutical products. The company was founded in 1992 and is headquartered in Bois-Colombes, France.

Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC.

Chiesi Pharma AB is a private company that engages in research and development, manufacturing, and selling of medicines. Chiesi Pharma AB is based in Stockholm, Sweden. It was founded in 1935 by Giacomo Chiesi, and the CEO is Olav Henrik Fromm.

Medtronic Italia SpA manufactures and supplies medical consumables, cardiac valves, and orthopedics prostheses. The company is headquartered in Milan, Italy.

Synovis Life Technologies, Inc. manufactures medical devices. It markets biological and mechanical products used by surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. The company was founded in July 1985 and is headquartered in St. Paul, MN.

Welch Allyn Protocol, Inc (Oregon) designs, manufactures, and markets patient monitoring instruments and systems. The company is based in Skaneateles, NY. The company was founded by James Moon. Welch Allyn Protocol, Inc (Oregon was acquired by Welch Allyn, Inc. on July 13, 2000 for $131.01 million.

Baxter Corporation Englewood engages in the provision of medical device solutions. The company was founded by Ronald Baxa and Brian E. Baldwin in 1975 and is headquartered in Deerfield, IL.

Cheetah Medical, Inc. develops and markets non-invasive blood monitoring system. The firm offers cheetah sensors, staling SV and cheetah nicom devices. It provides noninvasive hemodynamic monitoring technologies which are designed for use in critical care, operating room and emergency department settings for a wide variety of patient populations. The company was founded by Hanan Keren in 2000 and is headquartered in Newton Center, MA.

Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA.

Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954.

Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France.

Chiesi Ventures, Inc.(Chiesi Ventures) is an venture capital firm founded in 2014. The firm is headquartered in Boston, Massachusetts.

Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA.

Chiesi Hellas Pharmaceuticals SA provides research, development and sale of medicinal products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It offers solutions for the treatment of asthma and chronic obstructive pulmonary disease. The company is headquartered in Vrilissa, Greece.

DOC Generici Srl manufactures and distributes generic drugs. The firm offers medicines for the treatment of chronic diseases such as cardiovascular and neurological. The company was founded in 1996 and is headquartered in Milan, Italy.

Borealis Tech Ventures Srl (Management) (Borealis Tech Ventures), is an independent venture capital investment firm. The firm was founded by Vittorio Bertazzoni, Giampaolo Cagnin, Alessandro Chiesi, Francesco Mutti, Pietro Negra, Andrea Casalini in 2014. The firm is headquartered in Parma, Italy.

Matras Interplastic SpA is an Italian company that manufactures and distributes thermoplastic polymers and resins. The private company was founded in 1960. The CEO is Alessandro Chiesi.

Farmindustria is an association of pharmaceutical companies that are based in Italy. The private company provides an interactive map that shows the location of their offices, production sites, and research centers. Farmindustria is located in Rome, Italy. The Italian company promotes the value of the pharmaceutical industry in terms of employment, investment, innovation, research and development, production, and export. The company also provides updates on COVID-19 and information on the pharmaceutical industry.

Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark.

Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.

Chiesi Pharmaceuticals BV provides research, development and sale of medical products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company is headquartered in Rijswijk, the Netherlands.

Opocrin SpA engages in the manufacture and marketing of active ingredients for the pharmaceutical industry. Its products include Collagen Gel, Sodium and Calcium Heparin, Iron Complexes, Parnaparin, and Pulmonary Surfactant. The company was founded by Pietro Bianchini in 1964 and is headquartered in Modena, Italy.

Chiesi España SA manufactures and distributes pharmaceutical products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation, and neonatology. The firm produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It also provides solutions for the treatment of asthma and chronic obstructive pulmonary diseases. The company is headquartered in Barcelona, Spain.

Asche Chiesi GmbH provides research, development and sale of medicinal products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It offers solutions for the treatment of asthma and chronic obstructive pulmonary diseases. The company was founded in 2002 and is headquartered in Hamburg, Germany.